About this trial
The purpose of this randomized controlled study is to explore whether lavender sandalwood aromatherapy can support comfort, mood, pain relief, and overall satisfaction for participants recovering from a scheduled cesarean section without complications. The main questions this study aims to answer are:
* How does lavender sandalwood aromatherapy affect participants' mood during postpartum recovery after a cesarean section? * Does lavender sandalwood aromatherapy help reduce pain during recovery? * Does lavender sandalwood aromatherapy improve participants' overall satisfaction with their recovery experience? Researchers will compare participants who receive lavender-sandalwood aromatherapy with those who do not to determine whether it improves mood, reduces pain, and enhances patient satisfaction.
Participants will be asked to:
* Wear aromatherapy tabs on their gown for 24 hours. * Have the aromatherapy tabs applied 24 hours after the cesarean section and removed 48 hours after the cesarean section. * Complete surveys at 24 hours and 48 hours after the cesarean section. This will apply to both the control and intervention groups.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients scheduled for a planned cesarean section
Undergoing pre-admission testing
Disqualifiers
Individuals under 18 years of age
High-risk pregnancies
Patients not admitted to the postpartum unit following delivery
Individuals with known allergies to essential oils
Trial design
Parallel
Treatments tested in this trial
Lavender-sandalwood aromatherapy tabs
Other interventionThe intervention used in this study consists of aromatherapy tabs infused with lavender and sandalwood essential oils. These aromatabs are administered to participants following their cesarean section procedures to evaluate their effectiveness in managing postoperative pain. The choice of lavender and sandalwood is based on their widely recognized calming and analgesic properties, with the goal of providing non-pharmacological support for pain relief. Participants in the experimental group will receive these aromatabs according to the study protocol, allowing for a clear comparison of outcomes between the aromatherapy intervention and the control group.
Treatment groups
Trial outcomes
Primary outcomes
PANAS survey to measure mood
The primary outcome of this study focuses on evaluating participants' emotional well-being by utilizing the Positive and Negative Affect Schedule (PANAS). This assessment tool will be administered twice: first, at the baseline 24 hours after delivery, and then again at 48 hours following surgery. By comparing PANAS results from these two time points, the study aims to capture any changes in both positive and negative mood dimensions that may occur as a result of the intervention. This approach provides a comprehensive analysis of how the aromatherapy tabs may influence mood and emotional states during the immediate postoperative recovery period.
Secondary outcomes
DVPRS to Measure Pain and Patient Satisfaction
Pain assessment will use the Defense and Veterans Pain Rating Scale (DVPRS) at two intervals-around 24 hours after cesarean section (±4 hours), and at 48 hours post-surgery or before hospital discharge (within a 4-hour window, or at the last pain score before discharge if earlier). This method evaluates the effectiveness of aromatherapy in both control and experimental groups.
Other outcomes
Patient Satisfaction Scores
Patient satisfaction will be assessed using a Qualtrics-based adult patient satisfaction survey. The survey will include the Net Promoter Score and additional questions related to the participant's recovery experience, perceived comfort, and overall satisfaction with care. Responses will be scored according to Qualtrics guidance when applicable, and patient satisfaction results will be summarized descriptively to compare trends between the aromatherapy intervention group and the control group.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: